Table 1 Deaths prevented or postponed by medical and surgical treatments in Ireland in 2000.
Treatments | Number of eligible patients* | % Eligible patients treated† | Absolute risk reduction | Best estimate (number) | Best estimate (%) |
---|---|---|---|---|---|
Acute myocardial infarction (AMI) | 3970 | 166‡ | 4.4‡ | ||
Community resuscitation | 49 | 0.110 | 12 | 0.3 | |
Hospital resuscitation | 99 | 0.213 | 32 | 0.9 | |
Thrombolysis | 39‡‡ | 0.038 | 60 | 1.6 | |
Aspirin | 61‡‡ | 0.031 | 79 | 2.1 | |
Primary angioplasty | 4‡‡ | 0.056 | 8 | 0.2 | |
β blockers | 33 | 0.008 | 11 | 0.3 | |
ACE inhibitors | 19‡‡ | 0.001 | 11 | 0.3 | |
Total secondary prevention | 678§ | 18.0§ | |||
Secondary prevention after infarction | 37245 | 449¶ | 11.9¶ | ||
Aspirin | 64‡‡ | 0.010 | 127 | 3.4 | |
β blockers | 33 | 0.012 | 92 | 2.4 | |
ACE inhibitors | 21‡‡ | 0.012 | 53 | 1.4 | |
Statins | 37‡‡ | 0.015 | 83 | 2.2 | |
Warfarin | 4 | 0.008 | 9 | 0.2 | |
Rehabilitation | 51 | 0.014 | 87 | 2.3 | |
Secondary prevention after revascularisation | 24438 | 0.028 | 229** | 6.1** | |
Chronic angina | 317 | 8.4 | |||
CABG surgery | 18990 | 100 | 0.009 | 144 | 3.8 |
Angioplasty | 11023 | 100‡‡ | 0.005 | 45 | 1.2 |
Community angina (aspirin+statin) | 78873 | 75‡‡ | 0.002 | 128 | 3.4 |
Unstable angina | 2432 | 33 | 0.9 | ||
Aspirin and heparin | 59‡‡ | 0.012 | 17 | 0.5 | |
Aspirin alone | 30‡‡ | 0.013 | 8 | 0.2 | |
Platelet IIB/IIIA inhibitors | 48‡‡ | 0.007 | 8 | ||
Heart failure | – | 340 | 9.1 | ||
Hospital | 1715 | 28‡‡ | – | 150 | |
Community | 12940 | 56‡‡ | 190 | 5.1 | |
Hypertension treatment | 705648 | 37 | 0.001 | 59 | 1.6 |
Statins for primary prevention | 915169 | 6‡‡ | 0.001 | 46 | 1.2 |
Total treatment effects in 2000 | 1639/3763†† | 43.6 |
*Based on Hospital‐In‐Patient Enquiry, Central Statistics Office, and General Medical Payments Databases for the year 2000 only.23 †Treatment uptakes are weighted to sex and age groups by the year of death, and therefore not consistent with values in appendix III, and appendix III identifies the sources of treatment uptakes in Ireland for the year 2000 only. ‡This value does not include the additional 47 AMI deaths attributable to treatment effect of 1985. §This value equates to ¶ and ** together and does not include two additional deaths attributable to treatment effect of 1985. ††3763 is total observed fewer CHD deaths in 2000, and 1639 sums up all the individual bold font values. ‡‡These treatments were not generally available in 1985.